Tuesday, March 1, 2011
While awards programs that recognize creative healthcare-related advertisements or public awareness campaigns usually are won by agencies that represent large pharmaceutical companies or international health organizations, marketing campaigns that support clinical trial activities have begun to win these prizes, too.
An international consortium of pharmaceutical companies and academic institutions has created a massive database of clinical data that researchers hope can lead to better treatments for schizophrenia and depression.
The more a potential trial volunteer learns about the clinical trial process, the less likely he or she is to agree to participate.
To meet the challenges of research and development, the pharmaceutical industry must adopt more open source innovation—a concept that has been used for nearly three decades by the information technology sector—to promote innovation in the drug discovery process and boost bottom lines, according to a new report by Frost & Sullivan.
Global CRO Quintiles has stepped up expansion of its Global Prime Site program, which forms research partnerships with large hospitals and health systems capable of enrolling hundreds of clinical trial patients each year. Having established prime sites in California and Asia earlier this year, Quintiles has now signed strategic partnerships with Arizona State University (ASU) and the Seoul National University Hospital (SNUH), increasing its number of prime sites to seven.
Hailed as the largest outsourcing partnership between a contract research organization (CRO) and a pharmaceutical company, Covance and Sanofi-aventis have signed a 10-year agreement in which the CRO will provide France’s largest pharmaceutical company with a wide range of research and drug development services, and receive between $1.2 billion and $2.2 billion in revenue.